Wood board and process for its production

Information

  • Patent Grant
  • 10183416
  • Patent Number
    10,183,416
  • Date Filed
    Tuesday, October 25, 2016
    7 years ago
  • Date Issued
    Tuesday, January 22, 2019
    5 years ago
Abstract
The present application relates to wood boards, particularly post-cured wood boards and more particularly to particle board with excellent swelling properties; it also relates to a process for production of such boards.
Description
TECHNICAL FIELD

The present application relates to wood boards, particularly post-cured wood boards and more particularly to particle board with excellent swelling properties; it also relates to a process for production of such boards.


BACKGROUND

Particle board is a composite material which is typically manufactured from various kinds of wood particles, such as wood chips, sawmill shavings or saw dust. It can be used especially for the manufacture of various types of furniture, such as cabinets, kitchens, bath furniture and so forth. Generally, particle board (which is sometimes referred to as “chipboard”) is usually produced by mixing wood particles and a binder composition, e.g. a thermo-curable resin, subsequently forming the resulting mixture into a sheet and compressing said sheet under elevated temperatures. Most commonly, urea formaldehyde (UF), melamine urea formaldehyde (MUF) and phenol formaldehyde have been used as binder systems in particle board. Moreover, a variety of additives can be used, including waxes, dyes and release agents, which supplement the particle board with further desired properties. In order to improve the visual appearance and durability of particle board, veneer can be applied onto its visible surfaces.


Particle board has a variety of advantages over conventional wood products and plywood since it is cheaper, and generally denser and more uniform. As a consequence, in many applications particle board has replaced these conventional materials, predominantly for cost reasons.


However, one major disadvantage of particle board in certain applications is that it undergoes significant swelling upon exposure to moisture over a prolonged period of time. This is particularly based on the fact that, particularly urea formaldehyde particle board, is considerably hygroscopic. Exposure to humidity or direct contact with water usually leads to swelling of the material. As a consequence, appearance and strength of the particle board are significantly impaired. Due to this sensitivity to moisture, the application of particle board in humid environments can be disadvantageously restricted. Resistance to moisture and swelling are also important considerations for other types of wood boards, for example plywood, although the structure of plywood generally renders it less susceptible to moisture and swelling that particle board.


A wood board must, of course, satisfy a combination of requirements including satisfactory internal bond strength, modulus of elasticity, bending strength and dimensional stability. Resistance against decay, for example due to mould and/or biodegradation is also important.


It has previously been attempted to manufacture urea formaldehyde particle board having reduced swelling when exposed to moisture, e.g. by using higher amounts of binder. However, the use of significantly higher amounts of binder negatively affects the particle board's overall properties as well as cost efficiency and the cured UF binders still tend to be hydroscopic.


Moreover, it has been suggested to reduce swelling in UF/MUF particle board by applying heat to the finished product, whereby the particle board generally becomes less hygroscopic and hot pressing stress is relieved. However, even though such techniques may basically lead to reduced swelling of the particle board, the extensive application of heat also leads to degradation of the cured UF/MUF binders whereby the structural integrity of the product is negatively influenced.


One specific technical problem underlying the present invention is thus to overcome the above negative effects and to provide particle board with reduced swelling in the thickness direction and a process for producing such particle board.


SUMMARY

The above technical problem is solved according to the present invention by providing a process for manufacturing wood board, comprising the steps of:

    • (a) providing wood pieces;
    • (b) applying a carbohydrate binder composition to the wood pieces provided in step (a);
    • (c) forming the wood pieces obtained in step (b) into a sheet;
    • (d) heating and pressing the sheet obtained in step (c) to obtain a cured wood board; and
    • (e) post-curing the wood board obtained in step (d).


In one embodiment the wood board is a particle board and the invention provides a process for manufacturing particle board, comprising the steps:

    • (a) providing wood particles;
    • (b) mixing the wood particles provided in step (a) with a carbohydrate binder composition;
    • (c) forming the mixture obtained in step (b) into a sheet;
    • (d) heating and pressing the sheet obtained in step (c) to obtain a cured particle board; and
    • (e) post-curing the particle board obtained in step (d).





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows weight loss against swelling reduction in percent due to oven post curing at 140° C. for 24 hours. Binders were 40:40:20 DMH:FRU:HMDA, boards were pressed for 14 seconds/mm;



FIG. 2 shows the density reduction in board pieces when postcured at different temperatures for 16 hours. Binders were 40:40:20 DMH:FRU:HMDA, boards were pressed for 16 seconds/mm;



FIG. 3 shows the average thickness of samples before and just after postcuring at 140° C. and their reconditioned thickness. Binders were 40:40:20 DMH:FRU:HMDA, boards were pressed for 16 seconds/mm;



FIG. 4 shows the swelling reduction due to 16 hour post-curing at different temperatures. Binders were 40:40:20 DMH:FRU:HMDA, boards were pressed for 16 seconds/mm;



FIG. 5 shows the swelling reduction against standard swelling in percent when post-curing at 140° C. and 120° C. for varying lengths of time;



FIG. 6 shows RF wave post-cure temperature against internal bond strength (IB) and swelling results; and



FIG. 7 shows weight loss and swelling reduction due to microwave post-curing. Binders were 40:40:20 DMH:FRU:HMDA, boards were pressed for 14 seconds/mm.





DETAILED DESCRIPTION

Herein, the term “particle board” includes any kind of particle board which comprises wood particles and a binder composition. Examples of such particle board include medium-density fiberboards (MDF), hardboards or high-density fiberboards having various degrees of density and strength, as well as oriented strand board (OSB). The particle board may be uniform or may have a non-uniform structure, e.g. comprising different layers of material. For example, the particle board may have 3 layers, such as a core layer and two surface layers, wherein each layer may comprise a different wood material and/or grade of wood material and/or density and/or different binder compositions and/or amounts of binders.


The thickness of the particle board may be in the range of 5 to 100 mm. Preferred thicknesses are in the range of 10 to 45 mm or 16 to 22 mm. The thickness of the wood board may be ≥5 mm, ≥8 mm, ≥10 mm, or ≥15 mm and/or ≤100 mm, ≤80 mm, ≤60 mm, ≤50 mm, ≤45 mm or ≤25 mm.


The length of the wood board may be ≥1.5 m, ≥2 m, ≥2.5 m or ≥3 m and/or ≤8 m, ≤6 m or ≤5 m. The width of the wood board may be ≥1 m, ≥1.2 m, ≥1.5 m or ≥1.8 m and/or ≤4 m, ≤3 m or ≤3.5 m.


The term “wood particle” used herein includes any kind of wooden particles or fibers, such as wood chips, wood flakes, sawmill shavings and saw dust or mixtures thereof. Wood particles from both virgin wood and/or reclaimed wood can be used to produce the particle boards of the present invention. In addition, any kind of wood such as birch, beech, alder, pine, spruce, tropical wood and the like can be used as a source for said wood particles. According to the present invention, it is further possible to use mixtures of different types of wood in the manufacture of a particle board. Moreover, wood particles used in the process as defined above may be pre-dried to less than 8%, less than 6% or less than 5% moisture. For example the wood particles may be pre-dried to a moisture content of 1 to 5% moisture, e.g. 2 to 4% moisture or 1.5 to 3.5% moisture.


The expression “carbohydrate binder composition” according to the present invention includes any kind of carbohydrate-based binder composition which can be used for producing particle board or wood board. In contrast to the conventional UF/MUF binders employed in particle board manufacture, the carbohydrate binder used in the process of the present invention is preferably free of or essentially free of formaldehyde and may thus avoid issues associated with use and/or emissions of formaldehyde. Such carbohydrate binder compositions may be no-added formaldehyde binders.


The carbohydrate binder composition may be a binder composition that comprises at least 40% by dry weight carbohydrate(s); it may comprise at least 50%, at least 55% or at least 60% by dry weight carbohydrate(s).


Whilst not wishing to be bound by theory, it is believed that one advantage provided by the post-curing of the present invention associated with carbohydrate based binders is the possible breakdown or conversion of hygroscopic components in the binder, for example, hemicellulose when present, and the possible incorporation of such components in a cured form; it is believed that this reduces overall water pickup and/or retention and/or swelling. In this way, such degradation products may be useful in actually contributing to the binder efficiency. Furthermore, wood stress release and/or potential increased bacterial resistance may be achieved; for example, any hemicellulose present may support microbial growth and reduction and/or elimination of this or similar species may reduce any susceptibility of the finished product to decay, mould or biodegradation.


Preferably, subsequent to the step (d) of heating and pressing the sheet to obtain a cured wood board and prior to the step (e) of post-curing the wood board, the wood board has:


a) an internal bond strength of ≥0.1 N/mm2 or ≥0.15 N/mm2, preferably ≥0.2 N/mm2 and more preferably ≥0.25 N/mm2, notably measured according to EN 310:1993; and/or


b) a modulus of elasticity in bending of ≥1000 N/mm2, preferably ≥1200 N/mm2 and more preferably ≥1300 N/mm2, notably measured according to EN310:1993; and/or c) a bending strength of ≥5 N/mm2, preferably ≥7 N/mm2 and more preferably ≥10 N/mm2, notably measured according to EN310:1993.


According to one embodiment of the above-defined process, the carbohydrate binder composition comprises at least one carbohydrate component; it may comprise at least one carbohydrate component and at least one amine component.


Herein, the term “carbohydrate component” includes any carbohydrate compound which is capable of reacting (e.g. by application of heat) with the amine component, and optionally further crosslinkers, in order to form a suitably cured product. According to the present invention, the carbohydrate component may be selected from the group consisting of monosaccharides, disaccharides, polysaccharides or a reaction product thereof. The carbohydrate component may comprise at least one reducing sugar.


As used herein, the term “reducing sugar” indicates one or more sugars that contain aldehyde groups, or that can isomerize, i.e. tautomerize, to contain aldehyde groups, which groups may be oxidized with, for example, Cu-ions to afford carboxylic acids. According to the present invention, any such carbohydrate component may be optionally substituted, such as with hydroxy, halo, alkyl, alkoxy, and the like. In any such carbohydrate component, one or more chiral centers may be present, and both possible optical isomers at each chiral center are included in the invention described herein. Further, it is also to be understood that various mixtures, including racemic mixtures, or other diastereomeric mixtures of the various optical isomers of any such carbohydrate component, as well as various geometric isomers thereof, may be used in one or more embodiments described herein.


Moreover, while non-reducing sugars, for instance sucrose, may not be preferable, they may none the less be useful within the scope of the present invention, for example by in situ conversion to a reducing sugar. Further, it is also understood that a monosaccharide, a disaccharide, or a polysaccharide may be partially reacted with a precursor to form a carbohydrate reaction product. To the extent that the carbohydrate reaction product is derived from a monosaccharide, a disaccharide, or a polysaccharide, and maintains similar reactivity with the amine component to form reaction products similar to those of a monosaccharide, a disaccharide, or a polysaccharide with an amine component, the carbohydrate reaction product is within the scope of the expression “carbohydrate component”.


The carbohydrate binder composition may comprise a water soluble pre-reacted binder composition, comprising the reaction product(s) of (i) at least one carbohydrate component, and (ii) at least one nitrogen-containing component. The weight ratio between the carbohydrate component and the nitrogen-containing component may be 0.5:1 to 30:1.


The binder may be in the form of an aqueous solution or dispersion containing at least 20 wt.-%, for example at least 25% wt.-, 30% wt.-, 35% wt.-, 40% wt.-, 45 wt.-%, 50 wt.-%, 55 wt.-%, 60 wt.-%, 65 wt.-%, 70 wt.-%, 75 wt.-% or 80 wt.-% of said pre-reacted binder composition and/or no more than 85 wt.-%, for example no more that 80 wt.-%, 75 wt.-% or 70 wt.-% of said pre-reacted binder composition.


As used herein, the term “pre-reacted binder composition” includes any chemical composition obtainable and/or obtained by reacting a carbohydrate component and a nitrogen-containing component, which may be used as a binder, e.g. for binding loosely assembled matter, either as such or upon further modification.


The pre-reacted binder composition of preferred embodiments of the present invention is based on a carbohydrate component/nitrogen-containing component binder system, i.e. the carbohydrate component(s) and nitrogen-containing component(s) are not only present in small amounts in the starting material to prepare the pre-reacted binder composition of the present invention, but are the major components of the starting material. Accordingly, the total amount of the at least one carbohydrate component and the at least one nitrogen-containing component in the starting material to prepare the pre-reacted binder composition may be at least 20 wt.-%, based on the total weight of the binder composition before pre-reaction. For example, the total amount of the at least one carbohydrate component and the at least one nitrogen-containing component may be at least 30 wt.-%, 40 wt.-%, 50 wt.-%, 60 wt.-%, 70 wt.-%, 80 wt.-%, 90 wt.-%, 95 wt.-%, or 98 wt.-% before pre-reaction.


According to one embodiment of the present invention, the total amount of the reaction product(s) of (i) at least one carbohydrate component and (ii) at least one nitrogen-containing component, the unreacted carbohydrate component(s) and the unreacted nitrogen-containing component(s) in the pre-reacted binder composition, i.e. (amount of reaction product(s) of (i) and (ii))+(amount of unreacted carbohydrate component(s))+(amount of unreacted nitrogen-containing component(s)), is at least 20 wt.-%, based on the total weight of the pre-reacted binder composition, for example at least 30 wt.-%, 40 wt.-%, 50 wt.-%, 60 wt.-%, 70 wt.-%, 80 wt.-%, 90 wt.-%, 95 wt.-%, or 98 wt.-%.


The binder may be:

    • a binder disclosed in international patent application no. PCT/EP2013/057151;
    • a binder disclosed in U.S. patent application Ser. No. 13/696,439 (published as US 2013/0059075 A1); or
    • a binder disclosed in U.S. patent application Ser. No. 13/696,452 (published as US 2013/0047888 A1);


      each of which is hereby incorporated by reference.


Preferably, any carbohydrate component should be sufficiently non-volatile to maximize its ability to remain available for reaction with the amine component. The carbohydrate component may be a monosaccharide in its aldose or ketose form, including a triose, a tetrose, a pentose, a hexose, or a heptose; or a polysaccharide; or combinations thereof. For example, when a triose serves as the carbohydrate component, or is used in combination with other reducing sugars and/or a polysaccharide, an aldotriose sugar or a ketotriose sugar may be utilized (including glyceraldehyde and dihydroxyacetone, respectively). When a tetrose serves as the carbohydrate component, or is used in combination with other reducing sugars and/or a polysaccharide, aldotetrose sugars (including erythrose and threose) and ketotetrose sugars (including erythrulose), may be utilized. Moreover, when a pentose serves as the carbohydrate component, or is used in combination with other reducing sugars and/or a polysaccharide, aldopentose sugars (including ribose, arabinose, xylose, and lyxose) and ketopentose sugars (including ribulose, arabulose, xylulose, and lyxulose), may be utilized. When a hexose serves as the carbohydrate component, or is used in combination with other reducing sugars and/or a polysaccharide, aldohexose sugars (including glucose (i.e. dextrose), mannose, galactose, allose, altrose, talose, gulose, and idose) and ketohexose sugars (including fructose, psicose, sorbose and tagatose), may be utilized. When a heptose serves as the carbohydrate component, or is used in combination with other reducing sugars and/or a polysaccharide, a ketoheptose sugar (including sedoheptulose) may be utilized. Other stereoisomers of such carbohydrate components not known to occur naturally are also contemplated to be useful in preparing the binder compositions as described herein. In one embodiment, the carbohydrate component is high fructose corn syrup (HFCS).


As mentioned above, the carbohydrate component may be a polysaccharide. For example, the carbohydrate component may be polysaccharide with a low degree of polymerization and includes e.g. molasses, starch, cellulose hydrolysates, or mixtures thereof. According to a specific example, the carbohydrate component is a starch hydrolysate, a maltodextrin, or a mixture thereof. While carbohydrates of higher degrees of polymerization may not be preferable, they may none the less be useful within the scope of the present invention particularly by in situ depolymerization.


Furthermore, according to the present invention, the carbohydrate component may be used in combination with a non-carbohydrate polyhydroxy reactant. Examples of non-carbohydrate polyhydroxy reactants which can be used in combination with the carbohydrate component include, but are not limited to, trimethylolpropane, glycerol, pentaerythritol, polyvinyl alcohol, partially hydrolyzed polyvinyl acetate, fully hydrolyzed polyvinyl acetate, and mixtures thereof. For example, the non-carbohydrate polyhydroxy reactant is sufficiently non-volatile to maximize its ability to remain available for reaction with an amine component. Moreover, according to the present invention, the hydrophobicity of the non-carbohydrate polyhydroxy reactant may be a factor in determining the physical properties of a binder prepared as described herein.


Further, herein the expression “amine component” includes any chemical compound, or mixture of compounds, which contain(s) at least one nitrogen atom and which is/are capable of reacting with the at least one carbohydrate component.


According to the present invention, the at least one amine component may be selected from NH3, an inorganic amine or an organic amine comprising at least one primary amine group, as well as salts thereof. For example, as the amine component, NH3 may be used as such (e.g. in form of an aqueous solution), as well as in from of any type of inorganic and organic ammonium salt thereof, as long as these salts are capable of reacting with the carbohydrate component defined above. Specific examples of inorganic ammonium salts include ammonium sulfate (AmSO4), ammonium chloride, and ammonium nitrate.


Moreover, according to the present invention, the amine component may be a polyamine. Herein, the term “polyamine” includes any organic compound having two or more amine groups, which may independently be substituted or unsubstituted.


For example, the polyamine may be a primary polyamine. As used herein, a “primary polyamine” is an organic compound having two or more primary amine groups (—NH2). Within the scope of the term primary polyamine are those compounds which can be modified in situ or isomerize to generate a compound having two or more primary amine groups (—NH2).


According to one embodiment of the present invention, the primary polyamine may be a molecule having the formula H2N-Q-NH2, wherein Q is an alkyl, cycloalkyl, heteroalkyl, or cycloheteroalkyl, each of which may be optionally substituted. For example, Q may be an alkyl group selected from C2-C24, an alkyl group selected from C2-C9, or an alkyl group selected from C3-C7. According to a preferred embodiment, Q is a C6 alkyl. According to another embodiment, Q may be a cyclohexyl, cyclopentyl or cyclobutyl, or a benzyl group.


As used herein, the term “alkyl” includes a chain of carbon atoms, which may optionally be branched. It is to be further understood that alkyl is preferably of limited length, including C1-C24, C1-C12, C1-C8, C1-C6, and C1-C4. In particular, shorter alkyl groups may add less lipophilicity to the compound and accordingly will have different reactivity towards the carbohydrate component and solubility in a binder solution.


As used herein, the term “cycloalkyl” includes a chain of carbon atoms, which may optionally be branched, where at least a portion of the chain is cyclic. Moreover, according to the present invention it is to be noted that the term “cycloalkyl” also includes polycyclic structures. For example, such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, 2-methylcyclopropyl, cyclopentyleth-2-yl, adamantyl, and the like. Furthermore, the chain forming cycloalkyl is advantageously of limited length, including C3-C24, C3-C12, C3-C8, C3-C6, and C5-C6. According to the present invention, shorter alkyl chains forming cycloalkyl may add less lipophilicity to the compound and accordingly will have a different behavior.


As used herein, the term “heteroalkyl” includes a chain of atoms that includes both carbon and at least one heteroatom, and is optionally branched. Examples of such heteroatoms include nitrogen, oxygen, and sulfur. In certain variations, said hetero-atoms also include phosphorus, and selenium. In one embodiment, a heteroalkyl is a polyether. As used herein, the term “cycloheteroalkyl”, includes a chain of atoms that includes both carbon and at least one heteroatom, such as heteroalkyl, and may optionally be branched, where at least a portion of the chain is cyclic. Particularly, examples of cycloheteroalkyl include, but are not limited to, tetrahydrofuryl, pyrrolidinyl, tetrahydropyranyl, piperidinyl, morpholinyl, piperazinyl, homopiperazinyl, quinuclidinyl, and the like.


Herein, the term “optionally substituted” includes the replacement of hydrogen atoms with other functional groups. Such other functional groups include, but are not limited to, amino, hydroxyl, halo, thiol, alkyl, haloalkyl, heteroalkyl, aryl, arylalkyl, arylheteroalkyl, nitro, sulfonic acids and derivatives thereof, carboxylic acids and derivatives thereof, and the like. Moreover, according to the present invention, any of amino, hydroxyl, thiol, alkyl, haloalkyl, heteroalkyl, aryl, arylalkyl, arylheteroalkyl, and/or sulfonic acid is optionally substituted.


For example, the primary polyamine may be a diamine, triamine, tetramine, or pentamine. According to a specific embodiment, the polyamine is a triamine selected from a diethylenetriamine, 1-piperazineethaneamine, or bis(hexamethylene)triamine. In another embodiment, the polyamine is a tetramine, for example triethylenetetramine. In another embodiment, the polyamine is a pentamine, for example tetraethylenepentamine.


One feature of the primary polyamine is that it may possess low steric hindrance. For example, 1,2-diaminoethane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,12-diaminododecane, 1,4-diaminocyclohexane, 1,4-diaminobenzene, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, 1-piperazineethaneamine, 2-methyl-pentamethylenediamine, 1,3-pentanediamine, and bis(hexamethylene)triamine, as well as 1,8-diaminooctane have low steric hindrance within the scope of the present invention.


According to a preferred embodiment of the process as defined above, the amine component is the primary polyamine 1,6-diaminohexane (hexamethylenediamine, HMDA). In a further embodiment, the amine component is 1,5-diamino-2-methylpentane (2-methyl-pentamethylenediamine).


In another embodiment, the amine component is the primary polyamine polyether-polyamine. For example, according to the present invention, said polyether-polyamine is a diamine or a triamine. In one embodiment, the polyether-polyamine is a trifunctional primary amine having an average molecular weight of 440 known as Jeffamine T403 Polyetheramine (e.g. Huntsman Corporation).


In a further embodiment, the amine component may include a polymeric polyamine. For example, polymeric polyamines within the scope of the present invention include chitosan, polylysine, polyethylene imine, poly(N-vinyl-N-methyl amine), polyaminostyrene and polyvinylamines. In a specific example, the amine component comprises a polyvinyl amine. As used herein, the polyvinyl amine can be a homopolymer or a copolymer.


A further embodiment of the present invention relates to the above-defined process, wherein the at least one carbohydrate component is selected from the group consisting of ribose, arabinose, xylose, lyxose, glucose (dextrose), mannose, galactose, allose, altrose, talose, gulose, idose, fructose, psicose, sorbose, dihydroxyacetone, sucrose and tagatose, as well as mixtures thereof, and the at least one amine component is selected from the group consisting of ammonium sulfate (AmSO4), ammonium chloride, ammonium nitrate, 1,2-diaminoethane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,12-diaminododecane, 1,4-diaminocyclohexane, 1,4-diaminobenzene, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, 1-piperazineethaneamine, 2-methyl-pentamethylenedi-amine, 1,3-pentanediamine, and bis(hexamethylene)-triamine, 1,8-diaminooctane, as well as mixtures thereof.


The carbohydrate binder composition may be used in the form of a solution and/or dispersion of the at least one carbohydrate component and the at least one amine component in a solvent. Herein, the term “solvent” includes any solvent or mixture of solvents which may be used to dissolve or disperse the carbohydrate component and the amine component. For example, the solvent may be water, an organic solvent or mixtures thereof. Examples of organic solvents include alcohols, ethers, esters, ketones, aldehydes, alkanes and cycloalkanes.


The carbohydrate binder composition may be applied to, for example the wood particles, in the form of an aqueous solution or dispersion containing 10 to 95 wt.-%, 20 to 90 wt.-%, 30 to 85 wt.-%, or 40 to 80 wt.-% of total carbohydrate and amine components, based on the total weight of the solution or dispersion.


The amount of carbohydrate component and amine component includes such amounts which allow the formation of a cured binder. According to one embodiment of the process as defined above, the carbohydrate binder composition comprises 50 to 90 wt.-% of total carbohydrate component and 10 to 50 wt.-% of total amine component, based on the total content of carbohydrate and amine components.


According to a specific example of the present invention, in the above-defined process, the carbohydrate binder composition comprises 25 to 50 wt.-% of dextrose monohydrate (DMH), 25 to 50 wt.-% of fructose and 10 to 50 wt.-% of HMDA, based on the total content of carbohydrate and amine components.


Further examples include binder compositions comprising 10 to 90 wt.-%, 10 to 80 wt.-%, 10 to 70 wt.-%, 10 to 60 wt.-% or 10 to 50 wt.-% of DMH, 5 to 80 wt.-%, 10 to 70 wt.-%, 20 to 60 wt.-% or 30 to 50 wt.-% of fructose, and 5 to 50 wt.-%, 10 to 40 wt.-%, and 15 to 35 wt.-% HMDA, based on the total content of carbohydrate and amine components. It is understood that herein all upper and lower borders of ranges may be arbitrarily combined.


The carbohydrate component and the amine component may be used in stoichiometric amounts which result in an essentially complete curing reaction, or may be used in substoichiometric amounts. For example, the carbohydrate binder composition may be prepared by using less amine component than required for a stoichiometric reaction, and subsequent pre-curing said binder composition, e.g. by applying heat. This pre-reacted binder composition is then supplemented with the remaining amine component, e.g. to achieve a stoichiometric ratio. Using such pre-reacted binder compositions provides advantages regarding shelf life of the binder composition and can result in improved curing processes and better internal bond strength.


According to one embodiment of the present invention, in the carbohydrate binder composition, the ratio of carbonyl groups in the carbohydrate component to reactive amino groups in the amine component may be in the range of 5:1 to 1:2. For example, the ratio of carbonyl groups to reactive nitrogen-containing groups may be in the range of 5:1 to 1:1.8, 5:1 to 1:1.5, 5:1 to 1:1.2, 5:1 to 1:1, 5:1 to 1:0.8 and 5:1 to 1:0.5. Further examples include ratios such as 4:1 to 1:2, 3.5:1 to 1:2, 3:1 to 1:2, 2.5:1 to 1:2, 2:1 to 1:2 and 1.5:1 to 1:2.


Herein, the term “reactive amino group” includes any amino group in the amine component which is capable of reacting with the carbohydrate component. Specifically, examples of such reactive amino groups include primary and secondary amino groups, amide groups, imine and imide groups, as well as cyanate and isocyanate groups.


In contrast to the conventional UF/MUF binders employed in particle board manufacture, the use of a carbohydrate binder composition as defined herein is connected to a variety of advantages. For example, in contrast to UF/MUF binders, during post-curing, carbohydrate binders may undergo improved cure/crosslinking with wood break-down products and thus potentially result in improved binding properties. In addition, while UF/MUF binder systems are sensitive regarding exposure to elevated temperatures and tend to degrade under prolonged heat exposure, carbohydrate binder systems are thermally stable at the temperatures required for effectively post-curing particle board.


Finally, during the application of heat in the post-curing step, components of the wood, such as hemicellulose, may break down into sugars which potentially participate in the further curing process of the carbohydrate binder and lead to a stronger product.


Furthermore, it is currently thought that the post-curing of the invention may cause sugars which have not been transformed during initial curing to be transformed, cured or otherwise bound up with the carbohydrate binder during post-curing; they would thus no longer pose any potential detrimental effect for bacterial growth and, indeed, may positively contribute to the strength and/or other properties of the binder. If post-curing occurs at least partially at conditions under which released sugars, for example glucose, would not caramelise (for example below about 150° C. at pH9) the invention may provide a particular benefit of incorporating released sugar(s) into the binder. This may be the case in particular with a carbohydrate+amine binder system.


The carbohydrate binder, when cured, may comprise Maillard reaction products, for example melanoidins, and/or polyester components.


Herein, the term “post-curing” is not specifically restricted and simply means heating the particle board to a temperature above room temperature (20° C.).


Post-curing may provoke a temperature in the wood board, particularly in the core of the wood board, higher than that during initial curing. For example, during particle-board production the core of a particleboard rarely increases in temperature beyond 110-115° C. Post-curing may provoke a higher core temperature than in manufacture and thus produce an effect not seen during initial curing.


During the step of post curing the wood board, notably post curing using RF waves, the internal temperature of the wood board, notably the temperature at the centre of the wood board in its thickness direction, may be raised to a temperature of:


a) ≥100° C., ≥110° C., ≥115° C., ≥120° C., ≥130° C. or ≥140° C., and/or


b) ≤200° C., ≤180° C., ≤170° C. or ≤160° C.;


notably from a temperature at the end of the step of heating and pressing the board (d) which is lower that the temperature attained during the post-curing step by at least 5° C., at least 10° C. or at least 15° C.


In a further embodiment of the process as defined above, the post-curing in step (e) is carried out at a temperature in the range of 75° C. to 280° C. Further examples of the post-curing temperature include ranges of 80 to 260° C., 90 to 240° C., 110 to 220° C. and 130 to 210° C.


The post-curing step (e) of the above-defined process may be carried out by any suitable technique, such as by a heated press, a conventional oven, hot steam, by electromagnetic radiation (notable with a frequency between 1 MHz and 10 GHz) including microwaves and/or electromagnetic radiation in the radio frequency (RF) range. For example, the post-curing step (e) of the cured particle board obtained in step (d) may be performed by applying electromagnetic irradiation at an energy level of at least 50 W, or at least 80 W or at least 100 W and/or at less than 2000 W, less than 1500 W or less than 1000 W. The power of irradiation applied may be at least 5 kW/m2, at least 10 kW/m2 or at least 20 kW/m2; it may be no more than 200 kW/m2, no more than 150 kW/m2 or no more than 100 kW/m2. For example, typical microwave frequencies include 900 MHz and 2450 MHz, while typical RF wave frequencies includes 13, 17 or 40 MHz, without any limitation thereto. Where RF wave frequencies are used the frequency may be ≥0.5 MHz or ≥1 MHz or ≥5 MHz and/or ≤200 MHz or ≤150 MHz or ≤100 MHz.


Further, according to another example, it is envisaged that use of electromagnetic radiation, notably RF energy, for post-curing of timber boards would be used most effective if applied directly after board exit from the curing press. At this point in the manufacturing process, the internal temperature of the timber board will generally be reasonably high, for example above 100° C. This would reduce the input of electromagnetic energy required to reach a target post-cure temperature of, for example 140° C. or 160° C.


In another embodiment, the post-curing step (e) may be carried out by re-heating the particle board in a press at reduced contact pressure; such a procedure is advantageous in that no additional equipment would be required.


According to the present invention, in the process as defined above, heating in the post-curing in step (e) is carried out for a duration of 10 seconds to 30 hours. Further examples include heating periods of 2 minutes to 24 hours, 5 minutes to 18 hours, 10 minutes to 12 hours and 12 minutes to 8 hours. On the other hand, if electromagnetic waves, for example microwaves and/or RF waves, are applied as the energy source to apply heat during the post-curing step, the heating duration of step (e) can be advantageously reduced to much shorter times when compared to conventional heating by hot air and/or steam. If electromagnetic waves, for example microwaves or RF waves, are employed as the source of heat, heating periods of 10 seconds to 10 minutes, 20 seconds to 8 minutes, 40 seconds to 5 minutes, or 60 seconds to 3 minutes may be employed, depending on thickness and density of the particle board, as well as on the frequency and/or power of the electromagnetic waves. The rate of heating and/or the temperature generated using electromagnetic waves may also be controlled by controlling the amount of water present, for example by controlling the amount of water added and/or the amount of water within the substrate wood and/or the amount of any water generated during curing of the binder.


Prior to the post-curing step (e), a plurality of cured wood boards obtained from step (d) may be arranged to form a stack of wood boards, for example a stack comprising at least 2, 3, 4 or 5 wood boards and/or no more than 20, 15, 10 or 8 wood boards. The stack of wood boards may be arranged with each of the wood boards stacked one on top of the other, for example with each wood board substantially horizontal, and notably with each wood board having its surface covering or substantially covering the surface of adjacent wood boards preferably so that the stack has straight sides. The stack may have an overall thickness of ≥2 cm, ≥5 cm or ≥10 cm and/or ≤200 cm, ≤150 cm or ≤100 cm. The post-curing step (e), especially when using electromagnetic radiation, may be carried out a stack of wood boards.


The post-curing process as such will not only occur during the above-mentioned heating periods, but will continue as long as the temperature of the heated particle board is sufficiently high for the respective chemical curing reactions to take place. Accordingly, the post-curing periods may be significantly longer than the heating periods. For example, a stack of 3 to 10 (e.g. 4 to 8) particle boards might be heated by electromagnetic waves for 10 seconds to 5 minutes (e.g. for 30 seconds to 2 minutes) and subsequently stored in a thermally insulated environment in order to maintain the temperature for a prolonged time. This procedure would allow the rapid heating of multiple particle boards and provide post-heating conditions for a desirable degree of post-cure


In view of the above, the overall post-curing period may be in the range of 5 minutes to 72 hours, such as 10 minutes to 48 hours, 15 minutes to 36 hours, 30 minutes to 30 hours, 45 minutes to 24 hours, or 1 hours to 18 hours The overall post-curing may be at least 5 minutes and/or less than 2 hours, or less than 1 hour.


According to a further embodiment of the process as defined above, in step (d), the sheet obtained in step (c) is heated, e.g. in a hot press, with temperatures set in the range of 140° C. to 270° C. to obtain a cured particle-board. Further examples of typical temperatures to be applied in step (d) for preparing the particle board include temperatures set in the range of 150 to 250° C., 160 to 240° C. and 180 to 220° C.


According to another embodiment, in step (d) of the process of the present invention, the sheet obtained in step (c) is pressed, e.g. in a hot press, at a pressure in the range of 20 to 80 bar to obtain a cured particle board. Generally, the pressure to be applied during step (d) depends on various factors, such as type of wood and binder composition, thickness and density of the particle board, temperature, etc. In further examples, the pressure may be from 25 to 75 bar, 30 to 70 bar, or 35 to 65 bar.


According to a further embodiment, in step (d) of the above-defined process, the sheet obtained in step (c) is pressed at a press factor in the range of 2 seconds/mm to 60 seconds/mm to obtain a cured particle board. Thus, the press-time will depend on the thickness of the particle board, and may be, according to further examples of the present invention, in the range of 3 seconds/mm to 40 seconds/mm, 4 seconds/mm to 30 seconds/mm, or 5 seconds/mm to 20 seconds/mm.


The process according to the present invention may further comprise, between step (c) and step (d), a step (c′) of cold-compressing the sheet obtained in step (c).


In the following, further aspects of the present invention are described. However, it should be understood that all definitions provided above in relation to the process of the present invention also apply to the following aspects, if not stated otherwise.


Another aspect of the present invention relates to a wood board, notably a particle board, obtainable by the process as defined above.


In a further embodiment of the above-defined wood board, and particularly in respect of a particle board, swelling in the thickness-direction of the board as determined according to EN 317:1993 for an immersion time of 24 hours is 70% or below, preferably 60% or below and more preferably 50% or below.


Another aspect of the present invention relates to a particle board, characterized in that the swelling in the thickness-direction of the board as determined according to EN 317:1993 for an immersion time of 24 hours is 70% or below, preferably 60% or below and more preferably 50% or below.


In a preferred embodiment, the above-defined particle board shows swelling in the thickness-direction of the board as determined according to EN 317:1993 for an immersion time of 24 hours of 50% or below, 45% or below, 40% or below, 35% or below, or 30% or below. In even more preferred embodiments of the above-defined particle boards, swelling in the thickness-direction of the board as determined according to EN 317:1993 for an immersion time of 24 hours is 25% or below, 20% or below, 15% or below, 10% or below or even 5% or below.


The wood board may be plywood. In this case, the plywood preferably has a class 1 bonding quality, more preferably a class 2 bonding quality and most preferably a class 3 bonding quality according to the requirements of EN 314-2:1993 notably as tested according to EN 314-1:1993.


The wood board may be orientated strand board. Particularly in this case, the wood board may have:

    • A bending strength—major axis of at least 14 N/mm2, preferably at least 16 N/mm2 and more preferably at least 18 N/mm2, notably when measured according to EN 310:1993; and/or
    • A bending strength—minor axis of at least 6 N/mm2, preferably at least 7 N/mm2 and more preferably at least 8 N/mm2, notably when measured according to EN 310:1993; and/or
    • A modulus of elasticity in bending—major axis of at least 2500 N/mm2, preferably at least 3500 N/mm2, notably when measured according to EN 310:1993; and/or
    • A modulus of elasticity in bending—minor axis of at least 1200 N/mm2, preferably at least 1400 N/mm2, notably when measured according to EN 310:1993; and/or
    • An internal bond of at least 0.26 N/mm2, preferably at least 0.28 N/mm2 and more preferably at least 0.29 N/mm2, notably when measured according to EN 319:1993; and/or
    • A swelling in thickness—24 h immersion of no more than 25%, preferably no more than 20% and more preferably no more than 15%, notably when measured according to EN 317:1993.


The wood board may be dry process board (MDF) or fibreboard. Particularly in this case, the wood board may have:

    • A bending strength of at least 14 N/mm2, preferably at least 17 N/mm2 or 18 N/mm2 and more preferably at least 20 N/mm2, notably when measured according to EN 310:1993; and/or
    • A modulus of elasticity in bending of at least 1400 N/mm2, preferably at least 1700 N/mm2 or 1900 N/mm2, more preferably at least 2000 N/mm2 notably when measured according to EN 310:1993; and/or
    • An internal bond of at least 0.45 N/mm2, preferably at least 0.5 or 0.55 N/mm2 and more preferably at least 0.6 N/mm2, notably when measured according to EN 319:1993; and/or
    • A swelling in thickness—24 h of no more than 45%, preferably no more than 30% and more preferably no more than 20%, notably when measured according to EN 317:1993.


The wood board may be particle board. Particularly in this case, the wood board may have:

    • A bending strength of at least 7 N/mm2, preferably at least 8.5 N/mm2 or 11 N/mm2 and more preferably at least 13 N/mm2 or 14 N/mm2, notably when measured according to EN 310:1993; and/or
    • A modulus of elasticity in bending of at least 105 N/mm2, preferably at least 1200 N/mm2 or 1500 N/mm2, more preferably at least 1800 N/mm2 or 1900 N/mm2 notably when measured according to EN 310:1993; and/or
    • An internal bond of at least 0.2 N/mm2, preferably at least 0.25 N/mm2 and more preferably at least 0.3 N/mm2, notably when measured according to EN 319:1993; and/or
    • A swelling in thickness—24 h immersion of no more than 23%, preferably no more than 19% and more preferably no more than 16%, notably when measured according to EN 317:1993.


The following documents are hereby incorporated herein by reference: EN 300:2006; EN 310:1993; EN 314-1:1993; EN 314-2:1993; EN 317:1993; EN 319:1993


The present invention provides a process for manufacturing wood boards, notably particle boards, which are characterized by only little swelling upon contact with moisture, as well as boards obtainable by such a process. According to the present invention, thermal post-curing of wood boards is combined with the use of carbohydrate binder systems, which are especially suitable for such post-curing processes. As mentioned before, the carbohydrate binder systems used in the process of the present invention are preferably chosen to be thermally stable under the required conditions, undergo further curing during heat treatment and compatible with heat degradation products of the wood. Moreover, the use of added formaldehyde is preferably avoided.


In the following, the present invention is further illustrated by providing examples, without being restricted thereto.


Example 1: Production of Particle Board (300 mm×300 mm×10 mm)

A carbohydrate binder composition was prepared by adding HMDA (10.53 g) to pre-react solution consisting of 32.44 g dextrose monohydrate (DMH; 90.9 wt.-% in H2O), 29.59 g fructose (FRU; 100% solid), 10.53 g hexamethylene diamine (HMDA; 70 wt.-% in H2O) and 22.32 g of water. This carbohydrate binder composition corresponds to 40:40:20 wt.-% DMH:FRU:HMDA.


The binder composition (105.3 g; 70 wt.-% in H2O) and wood chips (526.5 g) were mixed and formed into a sheet, with a desired final density of 650 kg/m3. This sheet was pressed with a heated press (Fontijne Lab Econ 600) at 195° C. and 56 bar (504 kN force) pressure. The press factor was 14 s/mm, corresponding to a total press time of 140 seconds.


Subsequently, similar results were achieved at a press factor of about 10 s/mm and less.


Example 2: Swelling Measurements

Swelling measurements were conducted according to EN 317:1993, if not specified otherwise.


In particular, a thermostatically controlled water bath, capable of maintaining a temperature of (20±1)° C. was used. Particle board samples with a side length of (50±1) mm were prepared and conditioned to constant mass in an atmosphere with a mean relative humidity of (65±5) % and a temperature of (20±2)° C. Constant mass was considered to be reached when the results of two successive weighing operations, carried out at an interval of 24 h, did not differ by more than 0.1% of the mass of the sample. Next, the thickness of each sample was measured to an accuracy of ±0.01 mm at the intersection of the diagonals and the samples were immersed with their faces vertical in clean, still water, having a pH of 7±1 and a temperature of (20±1)° C. This temperature was maintained throughout the test period, which was 2 hours or 24 hours, depending on the experiments. During the test, the samples were separated from each other and from the bottom and the sides of the water bath. The upper edges of the test pieces were covered by (25±5) mm of water throughout the test.


Finally, after the immersion time has elapsed, the samples were taken out of the water, excess water was removed and the thickness was measured of each sample in the same way as mentioned before.


Example 3: Post-Curing of Particle Board (Weight Loss/Swelling Reduction)

Particle boards obtained according to Example 1 were subjected to post-curing in an oven at a temperature of 140° C. for 24 hours. Subsequently, the particle board samples (50±1 mm×50±1 mm×10±1 mm) were reconditioned as per initial conditioning mentioned above and weight loss and swelling reduction were determined and plotted against each other. The results are shown in FIG. 1.


Example 4: Density Reduction Measurements After Post-Curing

Particle board samples were obtained according to Example 1, except that a press factor of 16 seconds/mm was used, and were subjected to post-curing in an oven at different temperatures for 16 hours.


After post-curing and reconditioning, which was carried out as described above, the density was measured and compared to the initial density of the particle board samples. The results are plotted in FIG. 2, showing the reduction in density recorded comparing it before and after treatment.


Example 5: Thickness Measurements

Particle board samples were obtained according to Example 1, except that a press factor of 16 seconds/mm was used. Then, the initial thickness of the particle board samples (50±1 mm×50±1 mm×10±1 mm) was determined and subsequently, thicknesses of said samples after post-curing in an oven at 140° C. and after reconditioning, which was performed as described above, were measured. The results are shown in FIG. 3.


Example 6: Swelling Improvement After Post-Curing (Temperature-Dependent)

Particle board samples were obtained according to Example 1. Then, the particle board samples were subjected to post-curing in an oven at different temperatures (65° C., 90° C., 115° C. and 140° C.) for a duration for 16 hours. After said post-curing treatment, swelling was determined according to EN 317:1993 for immersion times of 2 and 24 hours, respectively. The results concerning swelling reduction are given in FIG. 4.


Example 7: Swelling Improvement After Post-Curing (Time-Dependent)

Particle board samples were obtained according to Example 1. Then, the particle board samples were subjected to post-curing in an oven at temperatures of 120° C. and 140° C. for different duration (30 min., 60 min., 90 min. and 120 min.). After said post-curing treatment, swelling was determined according to EN 317:1993 for immersion times of 2 and 24 hours, respectively. The results concerning swelling are given in FIG. 5.


Example 8: Post-Curing by RF Wave Irradiation

Particle board samples were obtained according to Example 1. Individual sample sizes were 100±1 mm×100±1 mm×10±1 mm. RF wave power was varied over the range from 200-800 W. This equates roughly with 20-80 kW/m2 for the sample size used. Some incidences of flaring were observed at the higher power levels which, essentially is the formation of a plasma which induces burning on the surface of the sample. Reduction of the power level prevented flaring but still allowed relatively rapid heating. At a power level of 500 W, a temperature of 140° C. was reached in about 60 seconds and 160° C. in about 80 seconds. At a power level of 400 W, 140° C. was reached in about 80 seconds and 160° C. in about 100 seconds. Temperatures in excess of 180° C. were reached but timings were not recorded due to difficulties with flaring and the need to reduce power input.


After said post-curing treatment, swelling was determined according to EN 317:1993 for immersion times of 2 and 24 hours, respectively. In addition internal bond strength was measured according to BS EN 319:1993. The resulting data is shown in FIG. 6.


Example 9: Influence of Microwave Post-Curing on Weight Loss/Swelling

Particle board samples were obtained according to Example 1 and post-cured in a standard household microwave (700 W) at full power for 40 and 60 seconds, respectively. Sample sizes were 50±1 mm×50±1 mm×10±1 mm. Subsequently, weight loss and swelling (measured according to EN 317:1993, immersion time 24 hours) was determined regarding an original (i.e. non-post-cured) particle board sample and samples having been post-cured for 40 and 60 seconds, respectively. The resulting data is shown in FIG. 7.

Claims
  • 1. A process for manufacturing wood board, comprising: (a) providing wood pieces;(b) applying a carbohydrate binder composition to the wood pieces provided in (a);(c) forming the wood pieces obtained in (b) into a sheet;(d) heating and pressing the sheet obtained in (c) to obtain a cured wood board; and(e) post-curing the wood board obtained in (d)wherein the carbohydrate binder composition applied to the wood pieces is selected from the group consisting of a) a binder composition which comprises at least 50% by dry weight reducing sugar(s), b) a binder composition which comprises at least 50% by dry weight water-soluble reaction product(s) of reducing sugar(s) and Maillard reaction amine component(s) and c) a binder composition which comprises at least 50% by dry weight of the combination of i) any unreacted sugar(s), ii) any unreacted Maillard reaction amine component(s) and iii) water-soluble reaction product(s) of reducing sugar(s) and Maillard reaction amine component(s).
  • 2. A process according to claim 1 for manufacturing particle board, comprising: (a) providing wood particles;(b) mixing the wood particles provided in (a) with a carbohydrate binder composition;(c) forming the mixture obtained in (b) into a sheet;(d) heating and pressing the sheet obtained in (c) to obtain a cured particle board; and(e) post-curing the particle board obtained in (d).
  • 3. The process according to claim 1, wherein the post-curing in (e) is carried out at a temperature in the range of 75° C. to 280° C.
  • 4. The process according to claim 1, wherein the post-curing (e) is carried out using radio frequency (RF) waves.
  • 5. The process according to claim 1, wherein the post-curing (e) is carried out using a heated press, a conventional oven, hot steam and/or microwaves.
  • 6. The process according to claim 1, wherein heating in the post-curing in (e) is carried out for a duration of 10 seconds to 30 hours.
  • 7. The process according to claim 1, wherein the binder composition comprises at least one reducing sugar reaction product.
  • 8. The process according to claim 1, wherein the binder composition comprises at least one reducing sugar and at least one Maillard reaction amine component.
  • 9. The process according to claim 8, wherein the at least one reducing sugar is selected from the group consisting of ribose, arabinose, xylose, lyxose, dextrose, mannose, galactose, allose, altrose, talose, gulose, idose, fructose, psicose, sorbose, dihydroxyacetone and tagatose, as well as mixtures thereof, andthe at least one Maillard reaction amine component is selected from the group consisting of ammonium sulfate (AmSO4), ammonium chloride, ammonium nitrate, 1,2-diaminoethane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,12-diaminododecane, 1,4-diaminocyclohexane, 1,4-diaminobenzene, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, 1-piperazine-ethanamine, 2-methyl-pentamethylenediamine, 1,3-pentanediamine, and bis(hexamethylene)-triamine, 1,8-diaminooctane, as well as mixtures thereof.
  • 10. The process according to claim 8, wherein the binder composition comprises 50 to 90 wt.-% of total reducing sugar and 10 to 50 wt.-% of total Maillard reaction amine component, based on the total content of reducing sugar and Maillard reaction amine components.
  • 11. The process according to claim 8, wherein the binder composition comprises 25 to 50 wt.-% of DMH, 25 to 50 wt.-% of fructose and 10 to 50 wt.-% of HMDA, based on the total content of reducing sugar and Maillard reaction amine components.
  • 12. The process according to claim 1, wherein, in (d), the sheet obtained in (c) is heated with temperatures set in the range of 140° C. to 270° C. to obtain a cured wood board.
  • 13. The process according to claim 1, wherein, in (d), the sheet obtained in (c) is pressed at a pressure in the range of 20 to 80 bar to obtain a cured wood board.
  • 14. The process according to claim 1, wherein, in (d), the sheet obtained in (c) is pressed at a press factor in the range of 2 seconds/mm to 60 seconds/mm to obtain a cured wood board.
  • 15. The process according to claim 1, wherein the process comprises the arrangement of a plurality of cured wood boards obtained from (d) to form a stack of wood boards and subjecting the stack of wood board to the post-curing (e).
  • 16. The process according to claim 1, wherein, during the post curing of the wood board (e), the internal temperature of the wood board at the centre of the wood board in its thickness direction is raised to a temperature of at least 110° C. from a temperature at the end of the heating and pressing of the board (d) which is lower than the temperature attained during the post-curing by at least 5° C.
  • 17. A wood board obtained or obtainable by the process as defined in claim 1.
  • 18. The wood board or particle board according to claim 17, wherein swelling in the thickness-direction of the board as determined according to EN 317:1993 for an immersion time of 24 hours is 70% or below.
  • 19. A method of reducing swelling in the thickness direction of a wood board when subjected to a swelling test comprising immersion in water, comprising manufacturing the wood board in accordance with claim 1.
  • 20. The process according to claim 1, wherein, during the post curing of the wood board (e), the internal temperature of the wood board at the centre of the wood board in its thickness direction is raised to a temperature of at least 110° C. from a temperature at the end of the heating and pressing of the board (d) which is lower than the temperature attained during the post-curing by at least 10° C.
  • 21. The process according to claim 1, wherein the wood board has a swelling in the thickness-direction as determined according to EN 317:1993 for an immersion time of 24 hours which is 70% or below.
  • 22. The process according to claim 1, wherein the wood board is selected from the group consisting of plywood, oriented strand board, dry process board, MDF, or fibreboard.
  • 23. The process according to claim 1, wherein the reducing sugar is obtained by conversion in situ from sucrose.
  • 24. The process according to claim 1, wherein the binder composition applied to the wood pieces comprises at least 60% by dry weight reducing sugar(s).
  • 25. A process for manufacturing wood particle board, comprising: (a) providing wood particles;(b) mixing the wood particles provided in (a) with a carbohydrate binder composition comprising at least 50% by dry weight reducing sugars;(c) forming the mixture obtained in (b) into a sheet;(d) heating and pressing the sheet obtained in (c) to obtain a cured particle board; and(e) post-curing the particle board obtained in (d)so that the particle board has the following properties: a thickness of the wood board is in the range of 10 to 45 mm, anda bending strength of at least 7 N/mm2, anda modulus of elasticity in bending of at least 1200 N/mm2, andan internal bond strength of at least 0.2 N/mm2.
  • 26. A process for manufacturing wood particle board, comprising: (a) providing wood particles;(b) mixing the wood particles provided in (a) with a carbohydrate binder composition consisting essentially of reactions product(s) of (i) at least one reducing sugar, and (ii) at least one Maillard reaction amine component;(c) forming the mixture obtained in (b) into a sheet;(d) heating and pressing the sheet obtained in (c) to obtain a cured particle board; and(e) post-curing the particle board obtained in (d)so that the particle board has the following properties: a thickness of the wood board is in the range of 10 to 45 mm, anda bending strength of at least 7 N/mm2, anda modulus of elasticity in bending of at least 1200 N/mm2, andan internal bond strength of at least 0.2 N/mm2.
Priority Claims (1)
Number Date Country Kind
1214734.4 Aug 2012 GB national
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/422,104, filed Feb. 17, 2015, which is a U.S. national counterpart application under 35 U.S.C. § 371 of International Application Serial No. PCT/EP2013/067204, filed Aug. 17, 2013, which claims priority to GB Application Serial No. 1214734.4, filed Aug. 17, 2012, the entire disclosures of which are expressly incorporated by reference herein.

US Referenced Citations (466)
Number Name Date Kind
1801052 Meigs Apr 1931 A
1801053 Meigs Apr 1931 A
1886353 Novotny Nov 1932 A
1902948 Castle Mar 1933 A
1964263 Krenke Jun 1934 A
2198874 Leighton Apr 1940 A
2215825 Wallace Sep 1940 A
2261295 Schlack Nov 1941 A
2362086 Eastes Nov 1944 A
2371990 Hanford Mar 1945 A
2392105 Sussman Jan 1946 A
2442989 Sussman Jun 1948 A
2500665 Courtright Mar 1950 A
2518956 Sussman Aug 1950 A
2875073 Gogek Feb 1959 A
2894920 Ramos Jul 1959 A
2965504 Gogek Dec 1960 A
3038462 Bohdan Jun 1962 A
3138473 Floyd Jun 1964 A
3222243 Gaston Dec 1965 A
3231349 Stalego Jan 1966 A
3232821 Banks Feb 1966 A
3297419 Eyre Jan 1967 A
3513001 Woodhead May 1970 A
3551365 Matalon Dec 1970 A
3784408 Jaffe Jan 1974 A
3791807 Etzel Feb 1974 A
3802897 Voigt Apr 1974 A
3809664 Burr May 1974 A
3826767 Hoover Jul 1974 A
3856606 Fan Dec 1974 A
3867119 Takeo Feb 1975 A
3907724 Higginbottom Sep 1975 A
3911048 Vargiu Oct 1975 A
3919134 Higginbottom Nov 1975 A
3922466 Bell Nov 1975 A
3955031 Jones May 1976 A
3956204 Higginbottom May 1976 A
3961081 McKenzie Jun 1976 A
3971807 Brack Jul 1976 A
4014726 Fargo Mar 1977 A
4028290 Reid Jun 1977 A
4048127 Gibbons et al. Sep 1977 A
4054713 Sakaguchi Oct 1977 A
4085076 Gibbons et al. Apr 1978 A
4097427 Aitken Jun 1978 A
4107379 Stofko Aug 1978 A
4109057 Nakamura Aug 1978 A
4144027 Habib Mar 1979 A
4148765 Nelson Apr 1979 A
4183997 Stofko Jan 1980 A
4184986 Krasnobajew Jan 1980 A
4186053 Krasnobajew Jan 1980 A
4201247 Shannon May 1980 A
4201857 Krasnobajew May 1980 A
4217414 Walon Aug 1980 A
4233432 Curtis, Jr. Nov 1980 A
4246367 Curtis, Jr. Jan 1981 A
4259190 Fahey Mar 1981 A
4265963 Matalon May 1981 A
4278573 Tessler Jul 1981 A
4296173 Fahey Oct 1981 A
4301310 Wagner Nov 1981 A
4310585 Shannon Jan 1982 A
4322523 Wagner Mar 1982 A
4330443 Rankin May 1982 A
4333484 Keritsis Jun 1982 A
4357194 Stofko Nov 1982 A
4361588 Herz Nov 1982 A
4379101 Smith Apr 1983 A
4393019 Geimer Jul 1983 A
4396430 Matalon Aug 1983 A
4400496 Butler, Jr. Aug 1983 A
4464523 Neigel Aug 1984 A
4506684 Keritsis Mar 1985 A
4520143 Jellinek May 1985 A
4524164 Viswanathan et al. Jun 1985 A
4631226 Jellinek Dec 1986 A
4654259 Stofko Mar 1987 A
4668716 Pepe et al. May 1987 A
4692478 Viswanathan Sep 1987 A
4714727 Hume, III Dec 1987 A
4720295 Bronshtein Jan 1988 A
4754056 Ansel et al. Jun 1988 A
4761184 Markessini Aug 1988 A
4780339 Lacourse Oct 1988 A
4828643 Newman May 1989 A
4845162 Schmitt Jul 1989 A
4906237 Johansson Mar 1990 A
4912147 Pfoehler Mar 1990 A
4918861 Carpenter et al. Apr 1990 A
4923980 Blomberg May 1990 A
4950444 Deboufie Aug 1990 A
4988780 Das Jan 1991 A
4992519 Mukherjee Feb 1991 A
5001202 Denis et al. Mar 1991 A
5013405 Izard May 1991 A
5037930 Shih Aug 1991 A
5041595 Yang Aug 1991 A
5089342 Dhein Feb 1992 A
5095054 Lay Mar 1992 A
5106615 Dikstein Apr 1992 A
5114004 Isono May 1992 A
5123949 Thiessen Jun 1992 A
5124369 Vandichel Jun 1992 A
5128407 Layton Jul 1992 A
5143582 Arkens et al. Sep 1992 A
5151465 Le-Khac Sep 1992 A
5167738 Bichot Dec 1992 A
5198492 Stack Mar 1993 A
5217741 Kawachi et al. Jun 1993 A
5218048 Abe et al. Jun 1993 A
5240498 Matalon Aug 1993 A
5278222 Stack Jan 1994 A
5300144 Adams Apr 1994 A
5300192 Hansen, Sr. Apr 1994 A
5308896 Hansen, Sr. May 1994 A
5318990 Strauss Jun 1994 A
5336753 Jung Aug 1994 A
5336755 Pape Aug 1994 A
5336766 Koga et al. Aug 1994 A
5340868 Strauss et al. Aug 1994 A
5352480 Hansen, Sr. Oct 1994 A
5371194 Ferretti Dec 1994 A
5387665 Misawa Feb 1995 A
5389716 Graves Feb 1995 A
5393849 Srinivasan Feb 1995 A
5416139 Zeiszler May 1995 A
5421838 Gosset Jun 1995 A
5424418 Duflot Jun 1995 A
5434233 Kiely Jul 1995 A
5447977 Hansen, Sr. Sep 1995 A
5470843 Stahl Nov 1995 A
5480973 Goodlad Jan 1996 A
5492756 Seale, Jr. Feb 1996 A
5498662 Tanaka Mar 1996 A
5503920 Alkire et al. Apr 1996 A
5534612 Taylor Jul 1996 A
5536766 Seyffer Jul 1996 A
5538783 Hansen et al. Jul 1996 A
5543215 Hansen et al. Aug 1996 A
5545279 Hall Aug 1996 A
5547541 Hansen et al. Aug 1996 A
5547745 Hansen et al. Aug 1996 A
5550189 Qin Aug 1996 A
5554730 Woiszwillo Sep 1996 A
5562740 Cook Oct 1996 A
5571618 Hansen, Sr. Nov 1996 A
5578678 Hartmann Nov 1996 A
5580856 Prestrelski Dec 1996 A
5582682 Ferretti Dec 1996 A
5583193 Aravindakshan Dec 1996 A
5589256 Hansen, Sr. Dec 1996 A
5589536 Golino Dec 1996 A
5607759 Hansen, Sr. Mar 1997 A
5608011 Eck Mar 1997 A
5609727 Hansen, Sr. Mar 1997 A
5614570 Hansen, Sr. Mar 1997 A
5620940 Birbara Apr 1997 A
5621026 Tanaka Apr 1997 A
5633298 Arfaei May 1997 A
5641561 Hansen Jun 1997 A
5643978 Darwin Jul 1997 A
5645756 Dubin Jul 1997 A
5660904 Andersen et al. Aug 1997 A
5661213 Arkens Aug 1997 A
5670585 Taylor Sep 1997 A
5672418 Hansen Sep 1997 A
5672659 Shalaby Sep 1997 A
5690715 Schiwek Nov 1997 A
5691060 Levy Nov 1997 A
5693411 Hansen, Sr. Dec 1997 A
5719092 Arrington Feb 1998 A
5719228 Taylor Feb 1998 A
5756580 Natori May 1998 A
5763524 Arkens Jun 1998 A
5788243 Harshaw et al. Aug 1998 A
5788423 Perkins Aug 1998 A
5807364 Hansen Sep 1998 A
5855987 Margel Jan 1999 A
5863985 Shalaby Jan 1999 A
5885337 Nohr Mar 1999 A
5895804 Lee, Sr. Apr 1999 A
5905115 Luitjes May 1999 A
5916503 Rettenbacher Jun 1999 A
5919528 Huijs Jul 1999 A
5919831 Philipp Jul 1999 A
5922403 Tecle Jul 1999 A
5925722 Exner et al. Jul 1999 A
5929184 Holmes-Farley et al. Jul 1999 A
5929196 Kissel et al. Jul 1999 A
5932344 Ikemoto Aug 1999 A
5932665 Deporter et al. Aug 1999 A
5932689 Arkens Aug 1999 A
5942123 McArdle Aug 1999 A
5954869 Elfersy et al. Sep 1999 A
5977224 Cheung Nov 1999 A
5977232 Arkens Nov 1999 A
5981719 Woiszwillo Nov 1999 A
5983586 Berdan, II et al. Nov 1999 A
5990216 Cai Nov 1999 A
5993709 Bonomo Nov 1999 A
6022615 Rettenbacher Feb 2000 A
6067821 Jackson May 2000 A
6071549 Hansen Jun 2000 A
6071994 Hummerich Jun 2000 A
6072086 James et al. Jun 2000 A
6077883 Taylor Jun 2000 A
6090925 Woiszwillo Jul 2000 A
6114033 Ikemoto Sep 2000 A
6114464 Reck Sep 2000 A
6133347 Vickers, Jr. Oct 2000 A
6136916 Arkens Oct 2000 A
6139619 Zaretskiy Oct 2000 A
6143243 Gershun Nov 2000 A
6171444 Nigam Jan 2001 B1
6171654 Salsman Jan 2001 B1
6180037 Anderson Jan 2001 B1
6194512 Chen Feb 2001 B1
6210472 Kwan Apr 2001 B1
6221958 Shalaby Apr 2001 B1
6221973 Arkens Apr 2001 B1
6231721 Quick, Sr. May 2001 B1
6274661 Chen Aug 2001 B1
6281298 Papsin, Jr. Aug 2001 B1
6299677 Johnson Oct 2001 B1
6299936 Reck Oct 2001 B1
6307732 Tsubaki Oct 2001 B1
6310227 Sarama Oct 2001 B1
6313102 Colaco et al. Nov 2001 B1
6319683 James et al. Nov 2001 B1
6331350 Taylor Dec 2001 B1
6331513 Zaid Dec 2001 B1
6340411 Hansen Jan 2002 B1
6348530 Reck Feb 2002 B1
6365079 Winkler Apr 2002 B1
6372077 Tecle Apr 2002 B1
6379739 Formanek Apr 2002 B1
6395856 Petty May 2002 B1
6403665 Sieker Jun 2002 B1
6407225 Mang et al. Jun 2002 B1
6410036 De Rosa Jun 2002 B1
6440204 Rogols Aug 2002 B1
6461553 Hansen, Sr. Oct 2002 B1
6468442 Bytnar Oct 2002 B2
6468730 Fujiwara Oct 2002 B2
6469120 Elfersy Oct 2002 B1
6475552 Shah Nov 2002 B1
6482875 Lorenz Nov 2002 B2
6495656 Haile Dec 2002 B1
6521339 Hansen, Sr. Feb 2003 B1
6525009 Sachdev Feb 2003 B2
6538057 Wildburg Mar 2003 B1
6547867 Rogols Apr 2003 B2
6555616 Helbing et al. Apr 2003 B1
6559302 Shah May 2003 B1
6562267 Hansen May 2003 B1
6596103 Hansen Jul 2003 B1
6613378 Erhan Sep 2003 B1
6638882 Helbing Oct 2003 B1
6638884 Quick Oct 2003 B2
6699945 Chen Mar 2004 B1
6706853 Stanssens et al. Mar 2004 B1
6719862 Quick, Sr. Apr 2004 B2
6730730 Hansen May 2004 B1
6753361 Kroner Jun 2004 B2
6818694 Hindi Nov 2004 B2
6821547 Shah Nov 2004 B2
6852247 Bytnar Feb 2005 B2
6858074 Anderson Feb 2005 B2
6861495 Barsotti Mar 2005 B2
6864044 Ishikawa Mar 2005 B2
6878800 Husemoen Apr 2005 B2
6884849 Chen Apr 2005 B2
6955844 Tagge Oct 2005 B2
6962714 Hei Nov 2005 B2
6989171 Portman Jan 2006 B2
6992203 Trusovs Jan 2006 B2
7018490 Hansen Mar 2006 B2
7029717 Ojima Apr 2006 B1
7067579 Taylor Jun 2006 B2
7083831 Koch Aug 2006 B1
7090745 Beckman Aug 2006 B2
7141626 Rodrigues Nov 2006 B2
7144474 Hansen et al. Dec 2006 B1
7195792 Boston Mar 2007 B2
7201778 Smith Apr 2007 B2
7201825 Dezutter Apr 2007 B2
7202326 Kuroda Apr 2007 B2
7241487 Taylor Jul 2007 B2
7458235 Beaufils Dec 2008 B2
7514027 Horres Apr 2009 B2
7655711 Swift Feb 2010 B2
7772347 Swift Aug 2010 B2
7795354 Srinivasan et al. Sep 2010 B2
7803879 Srinivasan et al. Sep 2010 B2
7807771 Swift Oct 2010 B2
7842382 Helbing Nov 2010 B2
7854980 Jackson et al. Dec 2010 B2
7883693 Sehl Feb 2011 B2
7888445 Swift Feb 2011 B2
7947765 Swift May 2011 B2
8114210 Hampson Feb 2012 B2
8182648 Swift May 2012 B2
8211923 Wagner Jul 2012 B2
8372900 Shooshtari Feb 2013 B2
8377564 Shooshtari Feb 2013 B2
8501838 Jackson et al. Aug 2013 B2
8680224 Zhang Mar 2014 B2
8691934 Helbing Apr 2014 B2
8900495 Pacorel Dec 2014 B2
9492943 Hand Nov 2016 B2
20010017427 Rosthauser Aug 2001 A1
20010046824 Nigam Nov 2001 A1
20020000100 Burg Jan 2002 A1
20020025435 Hansen, Sr. Feb 2002 A1
20020026025 Kuo Feb 2002 A1
20020028857 Holy Mar 2002 A1
20020032253 Lorenz Mar 2002 A1
20020042473 Trollsas Apr 2002 A1
20020091185 Taylor Jul 2002 A1
20020096278 Foster Jul 2002 A1
20020123598 Sieker Sep 2002 A1
20020130439 Kroner Sep 2002 A1
20020161108 Schultz Oct 2002 A1
20020197352 Portman Dec 2002 A1
20030005857 Minami Jan 2003 A1
20030040239 Toas Feb 2003 A1
20030044513 Shah Mar 2003 A1
20030066523 Lewis Apr 2003 A1
20030071879 Swenson Apr 2003 A1
20030116294 Kehrer Jun 2003 A1
20030134945 Capps Jul 2003 A1
20030148084 Trocino Aug 2003 A1
20030153690 Husemoen Aug 2003 A1
20030185991 Wigger Oct 2003 A1
20030203117 Bartkowiak Oct 2003 A1
20040002567 Chen Jan 2004 A1
20040019168 Soerens Jan 2004 A1
20040024170 Husemoen Feb 2004 A1
20040033269 Hei Feb 2004 A1
20040033747 Miller Feb 2004 A1
20040034154 Tutin Feb 2004 A1
20040038017 Tutin Feb 2004 A1
20040048531 Belmares Mar 2004 A1
20040077055 Fosdick Apr 2004 A1
20040079499 Dezutter Apr 2004 A1
20040087024 Bellocq May 2004 A1
20040087719 Rautschek May 2004 A1
20040122166 O'Brien-Bernini Jun 2004 A1
20040131874 Tutin Jul 2004 A1
20040144706 Beaufils Jul 2004 A1
20040152824 Dobrowolski Aug 2004 A1
20040161993 Tripp Aug 2004 A1
20040209851 Nelson Oct 2004 A1
20040213930 Halabisky Oct 2004 A1
20040220368 Li Nov 2004 A1
20040249066 Heinzman Dec 2004 A1
20040254285 Rodrigues Dec 2004 A1
20040260082 Van Der Wilden Dec 2004 A1
20050001198 Bytnar Jan 2005 A1
20050017394 Hochsmann Jan 2005 A1
20050027283 Richard Feb 2005 A1
20050033037 Trusovs Feb 2005 A1
20050048212 Clamen Mar 2005 A1
20050059770 Srinivasan Mar 2005 A1
20050171085 Pinto Aug 2005 A1
20050196421 Hunter Sep 2005 A1
20050202224 Helbing Sep 2005 A1
20050208852 Weber Sep 2005 A1
20050215153 Cossement Sep 2005 A1
20050245669 Clungeon Nov 2005 A1
20050275133 Cabell Dec 2005 A1
20050288479 Kuroda Dec 2005 A1
20060005580 Espiard Jan 2006 A1
20060044302 Chen Mar 2006 A1
20060099870 Garcia May 2006 A1
20060111480 Hansen May 2006 A1
20060124538 Morcrette Jun 2006 A1
20060135433 Murray Jun 2006 A1
20060141177 Ligtenberg Jun 2006 A1
20060179892 Horres Aug 2006 A1
20060188465 Perrier Aug 2006 A1
20060198954 Frechem Sep 2006 A1
20060231487 Bartley Oct 2006 A1
20060252855 Pisanova Nov 2006 A1
20060281622 Maricourt Dec 2006 A1
20070006390 Clamen Jan 2007 A1
20070009582 Madsen Jan 2007 A1
20070027281 Michl Feb 2007 A1
20070039520 Crews Feb 2007 A1
20070082983 Crews et al. Apr 2007 A1
20070123679 Swift May 2007 A1
20070123680 Swift May 2007 A1
20070129522 Burckhardt et al. Jun 2007 A1
20070142596 Swift Jun 2007 A1
20070158022 Heep Jul 2007 A1
20070184740 Keller Aug 2007 A1
20070191574 Miller Aug 2007 A1
20070270070 Othman Nov 2007 A1
20070287018 Tutin Dec 2007 A1
20070292618 Srinivasan et al. Dec 2007 A1
20070292619 Srinivasan et al. Dec 2007 A1
20070298274 Eriksson Dec 2007 A1
20080009209 Clamen Jan 2008 A1
20080009616 Frank Jan 2008 A1
20080051539 Kelly Feb 2008 A1
20080060551 Crews Mar 2008 A1
20080081138 Moore Apr 2008 A1
20080108741 Van Herwijnen May 2008 A1
20080160260 Wada Jul 2008 A1
20080160302 Asrar Jul 2008 A1
20080194738 Crews Aug 2008 A1
20090169867 Kelly Jul 2009 A1
20090170978 Kelly Jul 2009 A1
20090227732 Glockner Sep 2009 A1
20090301972 Hines Dec 2009 A1
20090304919 Wagner Dec 2009 A1
20090306255 Patel Dec 2009 A1
20090324915 Swift Dec 2009 A1
20100029160 Srinivasan Feb 2010 A1
20100058661 Jackson Mar 2010 A1
20100080976 Jackson Apr 2010 A1
20100084598 Jackson Apr 2010 A1
20100086726 Jackson Apr 2010 A1
20100087571 Jackson Apr 2010 A1
20100098947 Inoue Apr 2010 A1
20100117023 Dopico May 2010 A1
20100129640 Kelly May 2010 A1
20100130649 Swift May 2010 A1
20100175826 Huenig Jul 2010 A1
20100210595 Wagner Aug 2010 A1
20100222463 Brady Sep 2010 A1
20100222566 Fosdick Sep 2010 A1
20100282996 Jaffrennou Nov 2010 A1
20100301256 Hampson Dec 2010 A1
20100320113 Swift Dec 2010 A1
20110021672 Crews Jan 2011 A1
20110039111 Shooshtari Feb 2011 A1
20110040010 Shooshtari Feb 2011 A1
20110042303 Shooshtari Feb 2011 A1
20110045966 Shooshtari Feb 2011 A1
20110089074 Jackson Apr 2011 A1
20110135937 Swift Jun 2011 A1
20110190425 Swift Aug 2011 A1
20110220835 Swift Sep 2011 A1
20110256790 Toas Oct 2011 A1
20110260094 Hampson Oct 2011 A1
20110262648 Lee Oct 2011 A1
20110263757 Rand Oct 2011 A1
20110306726 Bailey Dec 2011 A1
20120133073 Pacorel May 2012 A1
20120156954 Eckert Jun 2012 A1
20130029150 Appley Jan 2013 A1
20130032749 Jaffrennou Feb 2013 A1
20130047888 Mueller Feb 2013 A1
20130059075 Appley Mar 2013 A1
20130082205 Mueller Apr 2013 A1
20130174758 Mueller Jul 2013 A1
20130234362 Swift Sep 2013 A1
20130236650 Swift Sep 2013 A1
20130237113 Swift Sep 2013 A1
20130244524 Swift Sep 2013 A1
20140091247 Jackson Apr 2014 A1
20140134909 Guo May 2014 A1
20140357787 Jobber Dec 2014 A1
Foreign Referenced Citations (114)
Number Date Country
8538765 Aug 1985 AU
9640921 Jul 1997 AU
1090026 Nov 1980 CA
2037214 Sep 1991 CA
2232334 Nov 1998 CA
2458333 Dec 1999 CA
2278946 Jan 2000 CA
2470783 Dec 2004 CA
1251738 May 2000 CN
1905054 Aug 1969 DE
4142261 Jun 1993 DE
4233622 Apr 1994 DE
4308089 Sep 1994 DE
102004033561 Sep 2005 DE
102005023431 Nov 2006 DE
0044614 Jan 1982 EP
0099801 Feb 1984 EP
354023 Feb 1990 EP
0461995 Dec 1991 EP
0524518 Jan 1993 EP
0547819 Jun 1993 EP
0583086 Feb 1994 EP
0714754 Jun 1996 EP
796681 Sep 1997 EP
0826710 Mar 1998 EP
856494 Aug 1998 EP
0873976 Oct 1998 EP
878135 Nov 1998 EP
0882756 Dec 1998 EP
0911361 Apr 1999 EP
915811 May 1999 EP
936060 Aug 1999 EP
976866 Feb 2000 EP
0990729 Apr 2000 EP
1038433 Sep 2000 EP
1193288 Apr 2002 EP
1084167 Sep 2002 EP
1268702 Jan 2003 EP
1382642 Jan 2004 EP
1486547 Dec 2004 EP
1522642 Apr 2005 EP
1698598 Sep 2006 EP
1767566 Apr 2007 EP
2223941 Sep 2010 EP
2253663 Nov 2010 EP
2614388 Oct 1988 FR
809675 Mar 1959 GB
926749 May 1963 GB
1391172 Apr 1975 GB
1469331 Apr 1977 GB
1512066 May 1978 GB
1525541 Sep 1978 GB
2047258 Nov 1980 GB
2078805 Jan 1982 GB
2173523 Oct 1986 GB
2251438 Jul 1992 GB
53113784 Oct 1978 JP
57101100 Jun 1982 JP
5811193 Jan 1983 JP
61195647 Aug 1986 JP
3-173680 Jul 1991 JP
05186635 Jul 1993 JP
7-034023 Feb 1995 JP
09157627 Jun 1997 JP
10234314 Sep 1998 JP
11035491 Feb 1999 JP
11181690 Jul 1999 JP
2000327841 Nov 2000 JP
2002293576 Sep 2002 JP
2003147276 May 2003 JP
2003238921 Aug 2003 JP
2004060058 Feb 2004 JP
2005306919 Nov 2005 JP
549563 Jan 2008 NZ
1765996 Aug 1995 RU
374400 Mar 1973 SU
1990007541 Jul 1990 WO
1992012198 Jul 1992 WO
1995034517 Dec 1995 WO
1997049646 Dec 1997 WO
1999036368 Jul 1999 WO
199947765 Sep 1999 WO
199960042 Nov 1999 WO
199960043 Nov 1999 WO
200058085 Oct 2000 WO
2001014491 Mar 2001 WO
2001059026 Aug 2001 WO
200200429 Jan 2002 WO
2003029496 Apr 2003 WO
2003071879 Sep 2003 WO
2003106561 Dec 2003 WO
2004076734 Sep 2004 WO
2005087837 Sep 2005 WO
2006044302 Apr 2006 WO
2006136614 Dec 2006 WO
2007014236 Feb 2007 WO
2007024020 Mar 2007 WO
2007050964 May 2007 WO
2007112335 Oct 2007 WO
2008089847 Jul 2008 WO
2008089851 Jul 2008 WO
2008141201 Nov 2008 WO
2009019235 Feb 2009 WO
2010139899 Dec 2010 WO
2011019590 Feb 2011 WO
2011019593 Feb 2011 WO
2011019597 Feb 2011 WO
2011019598 Feb 2011 WO
2011022224 Feb 2011 WO
2011022226 Feb 2011 WO
2011022227 Feb 2011 WO
2011138458 Nov 2011 WO
2011138459 Nov 2011 WO
2013150123 Oct 2013 WO
Non-Patent Literature Citations (176)
Entry
International Search Report and Written Opinion for PCT/US2008/059730, completed Sep. 22, 2008.
International Search Report and Written Opinion for PCT/US2008/069046, completed Sep. 25, 2008.
International Search Report for PCT/EP2008/060185, completed Oct. 23, 2008.
International Search Report for PCT/EP2011/057363, completed Sep. 5, 2011.
Ames, J.M., “The Maillard Browning Reaction—an Update,” Chemistry & Industry, No. 17, 1988, 4 pages.
“Gamma-aminopropyltrimethoxysilane, ”Hawley's Condensed Chemical Dictionary, 14th Edition, John Wiley & Sons, Inc., 2002, 1 page.
Hodge, J.E., Chemistry of Browning Reactions in Model Systems, 1953, J. Agric. Food Chem., vol. 1, No. 15, pp. 928-943.
Agyei-Aye et al., “The Role of Anion in the Reaction of Reducing Sugars with Ammonium Salts,” Carbohydrate Research 2002, 337: 2273-2277.
Laroque et al., “Kinetic study on the Maillard reaction. Consideration of sugar reactivity,” Food Chemistry 2008, 111: 1032-1042.
Bjorksten et al., “Polyester Resin—Glass Fiber Laminates,” Industrial and Engineering Chemistry (1954).
Dow Corning, “A Guide to Silane Solutions,” 2005.
Knauf Data Sheet, 2006.
Molasses Corporation, United States Sugar Corporation, http://www.sugalik.com/molasses/composition.html (Sep. 29, 2003).
Clamen, Guy, “Acrylic Thermosets: A Safe Alternative to Formaldehyde Resins,” Nonwovens World, Apr.-May 2004, pp. 96-102.
Opposition to AU 2006272595, Amended Statement of Grounds and Particulars, issued from Australian Patent Office, Jul. 6, 2012, 22 pages.
Decision re Opposition to AU 2006272595, issued from Australian Patent Office, Aug. 14, 2015, 25 pages.
Opposition to EP 1732968, Notice of Opposition: Prior Art, Scope of the Patent, Reasons for the Opposition, issued from European Patent Office, Mar. 8, 2012, 18 pages.
Decision re Opposition to EP 1732968, issued from the European Patent Office, Nov. 14, 2014, 5 pages.
Opposition to EA 019802, submitted to Eurasian Patent Office on Dec. 26, 2014, 36 pages.
Decision re Opposition to EA 019802, issued by Eurasian Patent Office on Aug. 18, 2015, 15 pages.
Owens Corning Retiree Update: What Goes Around, Comes Around: A tale of Natural Binders, revised Mar. 20, 2013 p. 4.
A.P. Bryant, “The Terminology of Sugars,” Industrial and Engineering Chemistry, vol. 26, No. 2, p. 231, Feb. 1934.
Food Flavor Chemistry, p. 162, Mar. 21, 2009 (English Abstract).
Office action for co-pending U.S. Appl. No. 12/524,502 (9 pages)—dated Sep. 21, 2012.
Office action for co-pending U.S. Appl. No. 12/524,502 (9 pages)—dated Apr. 4, 2013.
Office action for co-pending U.S. Appl. No. 12/524,512 (7 pages)—dated Aug. 6, 2012.
Office action for co-pending U.S. Appl. No. 12/524,512 (9 pages)—Apr. 1, 2013.
Office action for co-pending U.S. Appl. No. 12/524,512 (14 pages)—dated Nov. 12, 2014.
Office action for co-pending U.S. Appl. No. 12/524,512 (9 pages)—dated Jul. 10, 2015.
Office action for co-pending U.S. Appl. No. 12/524,512 (10 pages)—dated Mar. 23, 2016.
Office action for co-pending U.S. Appl. No. 12/524,512 (13 pages)—dated Oct. 5, 2016.
Office action for co-pending U.S. Appl. No. 12/524,512 (13 pages)—dated Apr. 6, 2018.
Office action for co-pending U.S. Appl. No. 12/524,469 (7 pages)—dated Jun. 7, 2012.
Office action for co-pending U.S. Appl. No. 12/524,469 (8 pages)—dated Jan. 29, 2013.
Office action for co-pending U.S. Appl. No. 12/524,469 (7 pages)—dated Aug. 20, 2013.
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Jun. 9, 2014.
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Oct. 17, 2014.
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Jul. 23, 2015.
Office action for co-pending U.S. Appl. No. 12/524,539 (13 pages)—dated Jun. 21, 2012.
Office action for co-pending U.S. Appl. No. 12/524,539 (13 pages)—dated Jun. 6, 2013.
Office action for co-pending U.S. Appl. No. 12/524,539 (12 pages)—Dec. 17, 2014.
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—Jul. 15, 2015.
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Mar. 23, 2016.
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Dec. 29, 2016.
Office action for co-pending U.S. Appl. No. 12/524,522 (4 pages)—dated Oct. 11, 2011.
Office action for co-pending U.S. Appl. No. 12/667,718 (5 pages)—dated Sep. 3, 2013.
Office action for co-pending U.S. Appl. No. 12/667,718 (6 pages)—dated Sep. 9, 2014.
Office action for co-pending U.S. Appl. No. 12/671,922 (10 pages)—dated Oct. 7, 2011.
Office action for co-pending U.S. Appl. No. 12/671,922 (10 pages)—dated May 10, 2012.
Office action for co-pending U.S. Appl. No. 12/671,922 (9 pages)—dated Sep. 23, 2014.
Office action for co-pending U.S. Appl. No. 12/671,922 (5 pages)—dated Apr. 4, 2016.
Office action for co-pending U.S. Appl. No. 13/388,408 (5 pages)—dated Aug. 15, 2013.
Office action for co-pending U.S. Appl. No. 13/371,829 (9 pages)—dated Dec. 20, 2012.
Office action for co-pending U.S. Appl. No. 13/371,829 (6 pages)—dated Jul. 12, 2013.
Office action for co-pending U.S. Appl. No. 13/371,829 (6 pages)—dated Aug. 12, 2014.
Office action for co-pending U.S. Appl. No. 13/637,794 (8 pages)—dated Aug. 12, 2013.
Office action for co-pending U.S. Appl. No. 13/637,794 (9 pages)—dated Mar. 26, 2014.
Office action for co-pending U.S. Appl. No. 13/696,439 (11 pages)—dated Jan. 8, 2014.
Office action for co-pending U.S. Appl. No. 13/696,452 (7 pages)—dated Jan. 13, 2015.
Office action for co-pending U.S. Appl. No. 13/696,452 (9 pages)—dated Oct. 27, 2015.
Office action for co-pending U.S. Appl. No. 13/702,144 (6 pages)—dated Jan. 10, 2014.
Office action for co-pending U.S. Appl. No. 13/702,144 (7 pages)—dated Jul. 29, 2014.
Office action for co-pending U.S. Appl. No. 13/823,818 (9 pages)—dated Mar. 26, 2015.
Office action for co-pending U.S. Appl. No. 13/866,368 (16 pages)—dated Aug. 29, 2013.
Office action for co-pending U.S. Appl. No. 13/866,368 (11 pages)—dated Apr. 16, 2014.
Office action for co-pending U.S. Appl. No. 13/866,368 (8 pages)—dated Aug. 21, 2014.
Office action for co-pending U.S. Appl. No. 13/866,419 (14 pages)—dated Sep. 20, 2013.
Office action for co-pending U.S. Appl. No. 13/866,419 (10 pages)—dated Apr. 25, 2014.
Office action for co-pending U.S. Appl. No. 13/866,419 (8 pages)—dated Oct. 9, 2014.
Office action for co-pending U.S. Appl. No. 13/866,419 (8 pages)—dated Sep. 25, 2015.
Office action for co-pending U.S. Appl. No. 13/868,233 (23 pages)—dated Aug. 13, 2013.
Office action for co-pending U.S. Appl. No. 13/868,233 (12 pages)—dated Apr. 15, 2014.
Office action for co-pending U.S. Appl. No. 13/868,233 (8 pages)—dated Oct. 7, 2014.
Office action for co-pending U.S. Appl. No. 13/868,233 (8 pages)—dated Jul. 16, 2015.
Office action for co-pending U.S. Appl. No. 13/868,238 (8 pages)—dated Jul. 16, 2014.
Office action for co-pending U.S. Appl. No. 12/976,379 (7 pages)—dated Jan. 10, 2012.
Office action for co-pending U.S. Appl. No. 12/976,379 (6 pages)—dated Jul. 27, 2012.
Office action for co-pending U.S. Appl. No. 12/976,379 (9 pages)—dated Mar. 7, 2013.
Office action for co-pending U.S. Appl. No. 12/976,379 (8 pages)—dated Aug. 20, 2013.
Office action for co-pending U.S. Appl. No. 12/599,858 (8 pages)—dated May 11, 2011.
Office action for co-pending U.S. Appl. No. 13/341,542 (8 pages)—dated Dec. 26, 2012.
Office action for co-pending U.S. Appl. No. 13/341,542 (7 pages)—dated Feb. 10, 2014.
Office action for co-pending U.S. Appl. No. 14/026,394 (6 pages)—dated Aug. 14, 2014.
Office action for co-pending U.S. Appl. No. 14/272,556 (14 pages)—dated Nov. 20, 2014.
Office action for co-pending U.S. Appl. No. 14/272,556 (12 pages)—dated Sep. 17, 2015.
Office action for co-pending U.S. Appl. No. 14/342,069 (17 pages)—dated Dec. 29, 2015.
Office action for co-pending U.S. Appl. No. 14/342,069 (22 pages)—dated Sep. 2, 2016.
Office action for co-pending U.S. Appl. No. 14/342,069 (21 pages)—dated Sep. 26, 2017.
Office action for co-pending U.S. Appl. No. 14/342,069 (21 pages)—dated Jun. 6, 2018.
Office action for co-pending U.S. Appl. No. 14/649,277 (9 pages)—dated Jul. 22, 2016.
Office action for co-pending U.S. Appl. No. 14/686,915 (8 pages)—dated Nov. 18, 2016.
Office action for co-pending U.S. Appl. No. 14/810,765 (7 pages)—dated Jan. 29, 2016.
Office action for co-pending U.S. Appl. No. 14/828,916 (8 pages)—dated Nov. 25, 2016.
Office action for co-pending U.S. Appl. No. 14/867,502 (9 pages)—dated Nov. 18, 2016.
Office action for co-pending U.S. Appl. No. 15/172,432 (16 pages)—dated Apr. 17, 2017.
Office action for co-pending U.S. Appl. No. 15/177,442 (17 pages)—dated May 19, 2017.
Office action for co-pending U.S. Appl. No. 15/378,159 (18 pages)—dated Mar. 2, 2017.
Office action for co-pending U.S. Appl. No. 15/222,122 (8 pages)—dated Nov. 20, 2017.
Office action for co-pending U.S. Appl. No. 15/310,837 (13 pages)—dated Jun. 21, 2018.
Office action for co-pending U.S. Appl. No. 15/411,972 (9 pages)—dated Jun. 14, 2018.
Other information—Narrative of verbal disclosure of Brian Swift (1 page)—dated May 13, 2014.
Petition for Inter Partes Review of U.S. Pat. No. 8,114,210 (52 pages, filed Jun. 12, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,114,210 (58 pages, filed Jun. 12, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with Petition for Inter Partes Review of U.S. Pat. No. 8,114,210).
1st Petition for Inter Partes Review of U.S. Patent No. D. 631,670 (68 pages, filed Jun. 19, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
2nd Petition for Inter Partes Review of U.S. Patent No. D. 631,670 (62 pages, filed Nov. 2, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Decision of PTAB regarding Institution of Inter Partes Review for U.S. Patent No. D. 631,670 (33 pages)—dated Jan. 12, 2016.
Decision2 of PTAB regarding Institution of Inter Partes Review for U.S. Patent No. D631,670 (27 pages)—dated May 9, 2016.
Final Written Decision of PTAB regarding Inter Partes Review of D. 631,670 based on 1st Petition (56 pages)—dated Jan. 11, 2017.
Final Written Decision of PTAB regarding Inter Partes Review of D. 631,670 based on 2nd Petition (55 pages)—dated May 8, 2017.
Court of Appeals for Federal Circuit Judgment from Appeal of PTAB Decisions in Inter Partes Reviews of U.S. Patent No. D. 631,670 (2 pages)—dated Jul. 13, 2018.
1st Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (61 pages, filed Jul. 1, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (70 pages, filed Jul. 1, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st Petition for Inter Partes Review of U.S. Pat. No. 8,940,089).
2nd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (56 pages, filed Jul. 10, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (67 pages, filed Jul. 10, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 2nd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089).
3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (62 pages, filed Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (76 pages, filed Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089).
Declaration of Dr. Elam Leed (11 pages, filed Jul. 1, Jul. 10, and Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089, respectively).
Declaration of Dr. Jonathan Vickers (10 pages, filed Jul. 1, Jul. 10, and Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089, respectively).
1st Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (60 pages, filed Jul. 29, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (72 pages, filed Jul. 29, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st Petition for Inter Partes Review of U.S. Pat. No. 9,039,827).
2nd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (51 pages, filed Aug. 5, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (65 pages, filed Aug. 5, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 2nd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827).
3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (57 pages, filed Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (75 pages, filed Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827).
Declaration of Dr. Elam Leed (11 pages, filed Jul. 29, Aug. 5, and Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827, respectively).
Declaration of Dr. Jonathan Vickers (10 pages, filed Jul. 29, Aug. 5, and Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827, respectively).
Petition for Inter Partes Review of U.S. Pat. No. 9,469,747 (67 pages, filed Mar. 20, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Petition for Inter Partes Review of U.S. Pat. No. 9,828,287 (86 pages, filed Mar. 23, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Petition for Inter Partes Review of U.S. Pat. No. 9,464,207 (78 pages, filed Mar. 28, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Petition for Inter Partes Review of U.S. Pat. No. 9,926,464 (74 pages, filed Mar. 30, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (20 pages)—Jul. 24, 2015.
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (23 pages)—Jul. 24, 2015.
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (31 pages)—Aug. 18, 2015.
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (4 pages)—Oct. 6, 2015.
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (4 pages)—Oct. 6, 2015.
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (4 pages)—Nov. 18, 2015.
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (8 pages)—Mar. 23, 2016.
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (8 pages)—Mar. 23, 2016.
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (8 pages)—Mar. 22, 2016.
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (17 pages)—Sep. 29, 2016.
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (18 pages)—Sep. 29, 2016.
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (22 pages)—Sep. 30, 2016.
Court of Appeals for Federal Circuit Judgment from Consolidated Appeal of PTAB Decisions in Ex Parte Reexamination of U.S. Pat. No. 7,888,445, 7,772,347 and 7,854,980 (5 pages)—Mar. 9, 2018.
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (34 pages)—May 1, 2015.
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (36 pages)—May 1, 2015.
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,854,980 (25 pages)—Jul. 30, 2015.
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (5 pages)—Dec. 9, 2015.
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (5 pages)—Dec. 9 , 2015.
Examiner's Determination on Patent Owner Response/Requester Comments after Board Decision in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (22 pages)—Oct. 17, 2016.
Examiner's Determination on Patent Owner Response/Requester Comments after Board Decision in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (17 pages)—Oct. 17, 2016.
Court of Appeals for Federal Circuit Opinion/Judgment from Appeal of PTAB Decision in Inter Partes Reexamination of U.S. Pat. No. 7,854,980 (13 pages)—Feb. 27, 2017.
Final Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (25 pages)—Sep. 8, 2017.
Final Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (24 pages)—Sep. 8, 2017.
Decision of PTAB re Request for Rehearing in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (7 pages)—Feb. 12, 2018.
Decision of PTAB re Request for Rehearing in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (7 pages)—Feb. 12, 2018.
Decision of PTAB regarding Institution of Inter Partes Review for U.S. Pat. No. 8,114,210 (20 pages)—Oct. 21, 2015.
Final Written Decision of PTAB regarding Inter Partes Review of U.S. Pat. No. 8,114,210 (39 pages)—dated Oct. 19, 2016.
Court of Appeals for Federal Circuit Judgment from Appeal of PTAB Decision in Inter Partes Review of U.S. Pat. No. 8,114,210 (5 pages)—Jan. 16, 2018.
Decision1 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (16 pages)—Dec. 17, 2015.
Decision2 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (19 pages)—Dec. 17, 2015.
Decision3 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (14 pages)—Dec. 17, 2015.
Decision1 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (16 pages)—Jan. 4, 2016.
Decision2 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (19 pages)—Jan. 4, 2016.
Decision3 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (14 pages)—Jan. 4, 2016.
Statement of Revocation Grounds re GB2496951—Claimant Rockwool International (May 21, 2018, 22 pages).
Statement of Revocation Grounds re GB2451719—Claimant Rockwool International (May 18, 2018, 22 pages).
File Wrapper re U.S. Pat. No. 2,965,504—Part 1 (10 pages).
File Wrapper re U.S. Pat. No. 2,965,504—Part 2 (14 pages).
File Wrapper re U.S. Pat. No. 2,965,504—Part 3 (14 pages).
Gogek Attorney Comments re U.S. Pat. No. 2,965,504—Apr. 6, 1960 (3 pages).
Gogek Affidavit Under Rule 132 re U.S. Pat. No. 2,965,504—Feb. 26, 1960 (3 pages).
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,926,464 (29 pages)—Oct. 2, 2018.
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,464,207 (28 pages)—Oct. 2, 2018.
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,469,747 (29 pages)—Oct. 3, 2018.
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,828,287 (22 pages)—Oct. 16, 2018.
Expert Report re Revocation of GB2451719 and GB2496951—Claimant Rockwool International (Nov. 12, 2018, 11 pages).
Related Publications (1)
Number Date Country
20170106561 A1 Apr 2017 US
Continuations (1)
Number Date Country
Parent 14422104 US
Child 15333670 US